Akgun Ince is a Rheumatology/Immunology physician affiliated with Ophthalmology Consultants. OpenAlex indexes 13 publications with 840 citations (h-index 8).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
522 N New Ballas Rd
Suite 240
Saint Louis, MO 631416857
Telephone
314-567-5100Registry record last updated 16 May 2012.
Industry payments
33 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- E.R. Squibb & Sons, L.L.C.Program year202511 payments
- ABBVIE INC.Program year202536 payments
- UCB, Inc.Program year202522 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
97.4%Interleukin-6 Receptor Antagonist47.8%Tocilizumab100%Actemra Actpen0%Part D + Part B<11 patientsTNF inhibitor25.6%Infliximab60%Golimumab40%Humira(Cf) Pen0%Enbrel Sureclick0%Enbrel0%Part D + Part B<11 patients+ 7 more classes in this area
Nervous system
0.8%Opioid Agonist0.5%Tramadol Hcl98%Oxycodone-Acetaminophen3%Part D<11 patientsGabapentinoids0.1%Gabapentin51%Pregabalin49%Part D≥29 patients+ 2 more classes in this area
Metabolism & gastrointestinal
0.7%Corticosteroid0.4%Prednisone100%Part D≥232 patientsAntidiarrheal microorganisms0.1%Folic Acid100%Part D≥74 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Assessing Rheumatoid Arthritis Disease Activity Measures in Ethnic Minority Patients in the United States
JCR Journal of Clinical Rheumatology
2025
Similar KOLs
Other experts from the same institution or the same specialty.
David J. Hunter
The University of Sydney
Aziz Sheikh
Universiti Malaysia Terengganu
Nima Hafezi‐Nejad
The University of Sydney
Gelin Xu
Second Affiliated Hospital of Nanjing Medical University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”